NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Chief legal correspondent Shannon Bream provides details on the Supreme Court’s ruling striking down all IEEPA tariffs. Constitutional law professor Jonathan Turley weighs in.Read More